Presentation TCT 2020 TAVR in Low Surgical Risk Patients - Evidence Updates From Evolut Low-Risk Presenter: Michael Reardon October 16, 2020
Presentation TCT 2020 TCT 465: Implantation Characteristics and Development of Hypoattenuated Leaflet Thickening in Low Risk Patients undergoing Transcatheter Aortic Valve Replacement Presenter: Jaffar Khan October 14, 2020
Presentation TCT 2020 TCT 281: Clinical Outcomes of Optical Coherence Tomography Detected High Risk Versus Low Risk Coronary Atherosclerotic Lesions in Medically Treated Fractional Flow Reserve Negative Lesions in Diabetes Mellitus Patients. The COMBINE Trial. Presenter: Elvin Kedhi October 14, 2020
Presentation TVT 2020 Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis Presenter: Bruce Rutkin June 20, 2020
Presentation Live Valves 2019 All AS Patients ( incl. Low-Risk) should be treated with TAVI Presenter: Christian W. Hamm December 10, 2019